FBIO logo

Fortress Biotech (FBIO) EBITDA

Annual EBITDA

-$133.64 M
+$60.05 M+31.00%

December 31, 2023


Summary


Performance

FBIO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOprofitabilitymetrics:

Quarterly EBITDA

-$21.07 M
+$5.08 M+19.42%

September 30, 2024


Summary


Performance

FBIO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOprofitabilitymetrics:

TTM EBITDA

-$108.43 M
-$15.11 M-16.19%

September 30, 2024


Summary


Performance

FBIO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFBIOprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

FBIO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.0%-253.8%+32.1%
3 y3 years-52.2%+66.4%+25.8%
5 y5 years-12.9%+17.6%-5.7%

FBIO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+31.0%-253.8%+66.4%-16.2%+47.1%
5 y5-year-52.2%+31.0%-253.8%+66.4%-26.5%+47.1%
alltimeall time-1282.9%+31.0%-911.8%+66.4%-5107.9%+47.1%

Fortress Biotech EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$21.07 M(-19.4%)
-$108.43 M(+16.2%)
Jun 2024
-
-$26.14 M(-27.1%)
-$93.32 M(-22.0%)
Mar 2024
-
-$35.84 M(+41.2%)
-$119.57 M(-10.5%)
Dec 2023
-$133.64 M(-31.0%)
-$25.38 M(+326.3%)
-$133.65 M(-16.3%)
Sep 2023
-
-$5.95 M(-88.6%)
-$159.65 M(-20.4%)
Jun 2023
-
-$52.40 M(+5.0%)
-$200.68 M(+1.2%)
Mar 2023
-
-$49.91 M(-2.9%)
-$198.28 M(+2.4%)
Dec 2022
-$193.69 M(+32.5%)
-$51.38 M(+9.4%)
-$193.69 M(-5.5%)
Sep 2022
-
-$46.99 M(-6.0%)
-$205.04 M(+3.3%)
Jun 2022
-
-$50.00 M(+10.3%)
-$198.45 M(+17.5%)
Mar 2022
-
-$45.32 M(-27.8%)
-$168.91 M(+15.6%)
Dec 2021
-$146.17 M(+66.4%)
-$62.73 M(+55.3%)
-$146.17 M(+45.4%)
Sep 2021
-
-$40.40 M(+97.5%)
-$100.54 M(+17.3%)
Jun 2021
-
-$20.45 M(-9.4%)
-$85.72 M(-4.8%)
Mar 2021
-
-$22.58 M(+32.0%)
-$90.00 M(+2.5%)
Dec 2020
-$87.82 M(-0.7%)
-$17.10 M(-33.1%)
-$87.82 M(-14.4%)
Sep 2020
-
-$25.58 M(+3.4%)
-$102.62 M(+5.1%)
Jun 2020
-
-$24.73 M(+21.2%)
-$97.61 M(+1.5%)
Mar 2020
-
-$20.41 M(-36.0%)
-$96.19 M(+8.0%)
Dec 2019
-$88.48 M(-25.3%)
-$31.90 M(+55.1%)
-$89.10 M(+0.8%)
Sep 2019
-
-$20.57 M(-11.8%)
-$88.41 M(-7.8%)
Jun 2019
-
-$23.32 M(+75.1%)
-$95.85 M(-2.5%)
Mar 2019
-
-$13.31 M(-57.3%)
-$98.30 M(-17.4%)
Dec 2018
-$118.40 M(+33.7%)
-$31.21 M(+11.4%)
-$119.06 M(+9.1%)
Sep 2018
-
-$28.02 M(+8.7%)
-$109.16 M(-3.7%)
Jun 2018
-
-$25.77 M(-24.4%)
-$113.40 M(+4.6%)
Mar 2018
-
-$34.07 M(+59.9%)
-$108.39 M(+23.7%)
Dec 2017
-$88.57 M
-$21.31 M(-34.0%)
-$87.62 M(+3.2%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$32.26 M(+55.4%)
-$84.93 M(+23.6%)
Jun 2017
-
-$20.75 M(+56.1%)
-$68.74 M(+7.8%)
Mar 2017
-
-$13.30 M(-28.5%)
-$63.75 M(-4.6%)
Dec 2016
-$66.47 M(+26.9%)
-$18.61 M(+15.8%)
-$66.84 M(+6.4%)
Sep 2016
-
-$16.07 M(+1.9%)
-$62.84 M(-5.2%)
Jun 2016
-
-$15.77 M(-3.8%)
-$66.27 M(+17.2%)
Mar 2016
-
-$16.39 M(+12.1%)
-$56.56 M(+8.0%)
Dec 2015
-$52.37 M(+175.3%)
-$14.62 M(-25.0%)
-$52.39 M(+26.7%)
Sep 2015
-
-$19.50 M(+221.7%)
-$41.35 M(+57.1%)
Jun 2015
-
-$6.06 M(-50.4%)
-$26.32 M(+5.9%)
Mar 2015
-
-$12.22 M(+241.8%)
-$24.84 M(+30.6%)
Dec 2014
-$19.02 M(-46.0%)
-$3.58 M(-19.9%)
-$19.02 M(-23.2%)
Sep 2014
-
-$4.46 M(-2.6%)
-$24.77 M(-10.4%)
Jun 2014
-
-$4.59 M(-28.3%)
-$27.64 M(-16.8%)
Mar 2014
-
-$6.40 M(-31.4%)
-$33.24 M(-5.6%)
Dec 2013
-$35.22 M(+30.7%)
-$9.32 M(+27.1%)
-$35.22 M(+3.3%)
Sep 2013
-
-$7.33 M(-28.0%)
-$34.11 M(+4.9%)
Jun 2013
-
-$10.18 M(+21.5%)
-$32.52 M(+13.0%)
Mar 2013
-
-$8.38 M(+2.0%)
-$28.78 M(+6.8%)
Dec 2012
-$26.94 M(-25.7%)
-$8.21 M(+42.8%)
-$26.94 M(+6.9%)
Sep 2012
-
-$5.75 M(-10.6%)
-$25.20 M(+9.7%)
Jun 2012
-
-$6.44 M(-1.5%)
-$22.98 M(+13.3%)
Mar 2012
-
-$6.54 M(+1.0%)
-$20.28 M(-44.1%)
Dec 2011
-$36.26 M(+275.2%)
-$6.47 M(+83.3%)
-$36.29 M(+11.2%)
Sep 2011
-
-$3.53 M(-5.5%)
-$32.63 M(+4.6%)
Jun 2011
-
-$3.74 M(-83.4%)
-$31.18 M(+13.6%)
Mar 2011
-
-$22.55 M(+700.0%)
-$27.45 M(+460.1%)
Dec 2010
-$9.66 M
-$2.82 M(+35.4%)
-$4.90 M(+135.4%)
Sep 2010
-
-$2.08 M
-$2.08 M

FAQ

  • What is Fortress Biotech annual EBITDA?
  • What is the all time high annual EBITDA for Fortress Biotech?
  • What is Fortress Biotech annual EBITDA year-on-year change?
  • What is Fortress Biotech quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Fortress Biotech?
  • What is Fortress Biotech quarterly EBITDA year-on-year change?
  • What is Fortress Biotech TTM EBITDA?
  • What is the all time high TTM EBITDA for Fortress Biotech?
  • What is Fortress Biotech TTM EBITDA year-on-year change?

What is Fortress Biotech annual EBITDA?

The current annual EBITDA of FBIO is -$133.64 M

What is the all time high annual EBITDA for Fortress Biotech?

Fortress Biotech all-time high annual EBITDA is -$9.66 M

What is Fortress Biotech annual EBITDA year-on-year change?

Over the past year, FBIO annual EBITDA has changed by +$60.05 M (+31.00%)

What is Fortress Biotech quarterly EBITDA?

The current quarterly EBITDA of FBIO is -$21.07 M

What is the all time high quarterly EBITDA for Fortress Biotech?

Fortress Biotech all-time high quarterly EBITDA is -$2.08 M

What is Fortress Biotech quarterly EBITDA year-on-year change?

Over the past year, FBIO quarterly EBITDA has changed by -$15.11 M (-253.81%)

What is Fortress Biotech TTM EBITDA?

The current TTM EBITDA of FBIO is -$108.43 M

What is the all time high TTM EBITDA for Fortress Biotech?

Fortress Biotech all-time high TTM EBITDA is -$2.08 M

What is Fortress Biotech TTM EBITDA year-on-year change?

Over the past year, FBIO TTM EBITDA has changed by +$51.22 M (+32.08%)